These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 30795801)

  • 1. Combining naproxen and a dual amylin and calcitonin receptor agonist improves pain and structural outcomes in the collagen-induced arthritis rat model.
    Katri A; Dąbrowska A; Löfvall H; Ding M; Karsdal MA; Andreassen KV; Thudium CS; Henriksen K
    Arthritis Res Ther; 2019 Feb; 21(1):68. PubMed ID: 30795801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A dual amylin and calcitonin receptor agonist inhibits pain behavior and reduces cartilage pathology in an osteoarthritis rat model.
    Katri A; Dąbrowska A; Löfvall H; Karsdal MA; Andreassen KV; Thudium CS; Henriksen K
    Osteoarthritis Cartilage; 2019 Sep; 27(9):1339-1346. PubMed ID: 31176015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does receptor balance matter? - Comparing the efficacies of the dual amylin and calcitonin receptor agonists cagrilintide and KBP-336 on metabolic parameters in preclinical models.
    Larsen AT; Mohamed KE; Sonne N; Bredtoft E; Andersen F; Karsdal MA; Henriksen K
    Biomed Pharmacother; 2022 Dec; 156():113842. PubMed ID: 36242844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dual amylin and calcitonin receptor agonist KBP-336 elicits a unique combination of weight loss, antinociception and bone protection - a novel disease-modifying osteoarthritis drug.
    Mohamed KE; Larsen AT; Melander S; Andersen F; Kerrn EB; Karsdal MA; Henriksen K
    Arthritis Res Ther; 2024 Jul; 26(1):129. PubMed ID: 38997785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The enduring metabolic improvement of combining dual amylin and calcitonin receptor agonist and semaglutide treatments in a rat model of obesity and diabetes.
    Larsen AT; Mohamed KE; Melander SA; Karsdal MA; Henriksen K
    Am J Physiol Endocrinol Metab; 2024 Aug; 327(2):E145-E154. PubMed ID: 38864815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment sequencing using the dual amylin and calcitonin receptor agonist KBP-336 and semaglutide results in durable weight loss.
    Thorsø Larsen A; Karsdal MA; Henriksen K
    Eur J Pharmacol; 2023 Sep; 954():175837. PubMed ID: 37329973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amelioration of joint disease in a rat model of collagen-induced arthritis by M40403, a superoxide dismutase mimetic.
    Salvemini D; Mazzon E; Dugo L; Serraino I; De Sarro A; Caputi AP; Cuzzocrea S
    Arthritis Rheum; 2001 Dec; 44(12):2909-21. PubMed ID: 11762952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual amylin and calcitonin receptor agonist treatment reduces biomarkers associated with kidney fibrosis in diabetic rats.
    Melander SA; Møller AL; Mohamed KE; Rasmussen DGK; Genovese F; Karsdal MA; Henriksen K; Larsen AT
    Am J Physiol Endocrinol Metab; 2023 Nov; 325(5):E529-E539. PubMed ID: 37792041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Dual Amylin and Calcitonin Receptor Agonist KBP-088 Induces Weight Loss and Improves Insulin Sensitivity Superior to Chronic Amylin Therapy.
    Larsen AT; Sonne N; Andreassen KV; Gehring K; Karsdal MA; Henriksen K
    J Pharmacol Exp Ther; 2019 Jul; 370(1):35-43. PubMed ID: 31028106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KBP-066A, a long-acting dual amylin and calcitonin receptor agonist, induces weight loss and improves glycemic control in obese and diabetic rats.
    Andreassen KV; Larsen AT; Sonne N; Mohamed KE; Karsdal MA; Henriksen K
    Mol Metab; 2021 Nov; 53():101282. PubMed ID: 34214708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Calcitonin Receptor Plays a Major Role in Glucose Regulation as a Function of Dual Amylin and Calcitonin Receptor Agonist Therapy.
    Larsen AT; Sonne N; Andreassen KV; Karsdal MA; Henriksen K
    J Pharmacol Exp Ther; 2020 Jul; 374(1):74-83. PubMed ID: 32317372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic effects of lactosyl derivative Gu-4 in a collagen-induced arthritis rat model.
    Fan J; Zhou H; Wang S; Wang H; Zhang Y; Guo Y; Li Q; Li Z; Zhao Z
    Glycoconj J; 2012 Aug; 29(5-6):305-13. PubMed ID: 22688516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are insulin sensitizers the new strategy to treat Type 1 diabetes? A long-acting dual amylin and calcitonin receptor agonist improves insulin-mediated glycaemic control and controls body weight.
    Melander SA; Larsen AT; Karsdal MA; Henriksen K
    Br J Pharmacol; 2024 Jun; 181(12):1829-1842. PubMed ID: 38378168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual amylin and calcitonin receptor agonist treatment improves insulin sensitivity and increases muscle-specific glucose uptake independent of weight loss.
    Larsen AT; Melander SA; Sonne N; Bredtoft E; Al-Rubai M; Karsdal MA; Henriksen K
    Biomed Pharmacother; 2023 Aug; 164():114969. PubMed ID: 37269811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KBP-088, a novel DACRA with prolonged receptor activation, is superior to davalintide in terms of efficacy on body weight.
    Gydesen S; Andreassen KV; Hjuler ST; Christensen JM; Karsdal MA; Henriksen K
    Am J Physiol Endocrinol Metab; 2016 May; 310(10):E821-7. PubMed ID: 26908506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with a dual amylin and calcitonin receptor agonist improves metabolic health in an old, obese, and ovariectomized rat model.
    Katri A; Reker D; Karsdal MA; Bay-Jensen AC; Henriksen K
    Menopause; 2021 Jan; 28(4):423-430. PubMed ID: 33399320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling Sex Differences in Pharmacokinetics, Pharmacodynamics, and Disease Progression Effects of Naproxen in Rats with Collagen-Induced Arthritis.
    Li X; DuBois DC; Almon RR; Jusko WJ
    Drug Metab Dispos; 2017 May; 45(5):484-491. PubMed ID: 28246127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AM833 Is a Novel Agonist of Calcitonin Family G Protein-Coupled Receptors: Pharmacological Comparison with Six Selective and Nonselective Agonists.
    Fletcher MM; Keov P; Truong TT; Mennen G; Hick CA; Zhao P; Furness SGB; Kruse T; Clausen TR; Wootten D; Sexton PM
    J Pharmacol Exp Ther; 2021 Jun; 377(3):417-440. PubMed ID: 33727283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrogen sulfide releasing naproxen offers better anti-inflammatory and chondroprotective effect relative to naproxen in a rat model of zymosan induced arthritis.
    Dief AE; Mostafa DK; Sharara GM; Zeitoun TH
    Eur Rev Med Pharmacol Sci; 2015 Apr; 19(8):1537-46. PubMed ID: 25967731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.